Bulletin
Investor Alert

New York Markets Open in:

June 11, 2020, 5:41 a.m. EDT

Point-Of-Care Diagnostics Market Research Report 2020 Growth, Recent Trends and Forecast to 2026; Danaher Corporation (US: DHR), Trinity Biotech plc (US: TRIB), Abbott Laboratories(US: ABT)

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Danaher Corp. (DHR)
  • X
    Trinity Biotech PLC ADR (TRIB)
  • X
    Abbott Laboratories (ABT)

or Cancel Already have a watchlist? Log In

/zigman2/quotes/210555154/composite DHR +1.49% /zigman2/quotes/209008677/composite TRIB -3.21% /zigman2/quotes/203724446/composite ABT +0.04%

Jun 11, 2020 (Market Insight Reports) -- The report "Point-Of-Care Diagnostics Market" will be useful to get a stronger and effective Business Outlook. It provides an in-depth analysis of different attributes of industries such as trends, SWOT analysis, policies, and clients operating in several regions. The Qualitative and Quantitative Analysis Techniques have been used by analysts to provide accurate and applicable data to the readers, business owners, and industry experts.

The Global Point-Of-Care Diagnostics Market was valued at USD 24.26 Billion in 2018 and is projected to reach USD 51.6 Billion by 2026, growing at a CAGR of 9.9% from 2019 to 2026.

Top Companies in the global Point-Of-Care Diagnostics Market are
Danaher Corporation /zigman2/quotes/210555154/composite DHR +1.49% , Trinity Biotech plc /zigman2/quotes/209008677/composite TRIB -3.21% , Abbott Laboratories /zigman2/quotes/203724446/composite ABT +0.04% , Roche Diagnostics, Accubiotech, EKF Diagnostics, and Others.

Click here to get the latest sample PDF copy of Point-Of-Care Diagnostics Market with updated research 2020 https://www.marketinsightsreports.com/reports/06102084740/global-point-of-care-diagnostics-market/inquiry?mode=72&source=MW

Point-of-care (POC) diagnostics provide rapid actionable information for patient care at the time and site of an encounter with the health care system. The usual platform has been the lateral flow immunoassay.

More patients are preferring for Point-Of-Care (POC) diagnosis. The market is anticipated to propel due to several advantages it has to offer such as convenience, reduced patients’ waiting time, fewer or no follow-ups, accurate test results, immediate planning for treatment, and improved healthcare delivery. Hospital visits become difficult for the geriatric population and a rise in the geriatric population is helping the market to grow. With such type of diagnosis, the spread of infectious diseases is also brought under control. Growing support from various Governments across the world in rapid diagnosis has helped in market growth. However, lack of awareness and poor progress in developing countries are the biggest restraints in the market.

Browse full report description with TOC
https://www.marketinsightsreports.com/reports/06102084740/global-point-of-care-diagnostics-market?mode=72&source=MW

Regions covered By Point-Of-Care Diagnostics Market Report 2020 To 2026 are
North America (The United States, Canada, and Mexico), Asia-Pacific (China, India, Japan, South Korea, Australia, Indonesia, Malaysia, and Others), Europe (Germany, France, UK, Italy, Russia, and Rest of Europe), Central & South America (Brazil, and Rest of South America), and Middle East & Africa (GCC Countries, Turkey, Egypt, South Africa and Other)

Effect of the Point-Of-Care Diagnostics market report is
– A comprehensive evaluation of all opportunities and risks in the market.
– Point-Of-Care Diagnostics market current developments and significant occasions.
– A deep study of business techniques for the development of the market-driving players.
– Conclusive study about the improvement plot of the market for approaching years.
– Top to the bottom approach of market-express drivers, targets, and major littler scale markets.
– Favorable impressions inside imperative mechanical and publicize the latest examples striking the market.

Contact UsIrfan Tamboli (Sales Manager) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

COMTEX_366791193/2599/2020-06-11T05:41:19

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

/zigman2/quotes/210555154/composite
US : U.S.: NYSE
$ 206.83
+3.03 +1.49%
Volume: 2.07M
Aug. 3, 2020 4:03p
P/E Ratio
51.01
Dividend Yield
0.35%
Market Cap
$144.58 billion
Rev. per Employee
$280,183
loading...
/zigman2/quotes/209008677/composite
US : U.S.: Nasdaq
$ 2.41
-0.08 -3.21%
Volume: 295,691
Aug. 3, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$52.05 million
Rev. per Employee
$174,336
loading...
/zigman2/quotes/203724446/composite
US : U.S.: NYSE
$ 100.68
+0.04 +0.04%
Volume: 3.67M
Aug. 3, 2020 4:04p
P/E Ratio
58.03
Dividend Yield
1.43%
Market Cap
$178.19 billion
Rev. per Employee
$296,874
loading...
/zigman2/quotes/210555154/composite
US : U.S.: NYSE
$ 206.83
+3.03 +1.49%
Volume: 2.07M
Aug. 3, 2020 4:03p
P/E Ratio
51.01
Dividend Yield
0.35%
Market Cap
$144.58 billion
Rev. per Employee
$280,183
loading...
/zigman2/quotes/209008677/composite
US : U.S.: Nasdaq
$ 2.41
-0.08 -3.21%
Volume: 295,691
Aug. 3, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$52.05 million
Rev. per Employee
$174,336
loading...
/zigman2/quotes/203724446/composite
US : U.S.: NYSE
$ 100.68
+0.04 +0.04%
Volume: 3.67M
Aug. 3, 2020 4:04p
P/E Ratio
58.03
Dividend Yield
1.43%
Market Cap
$178.19 billion
Rev. per Employee
$296,874
loading...

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.